Bank of New York Mellon’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
269,664
+37,038
| +16% | +$353K | ﹤0.01% | 2617 |
|
|
2025
Q1 | $2.43M | Sell |
232,626
-2,172
| -0.9% | -$22.7K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $5.53M | Buy |
234,798
+698
| +0.3% | +$16.4K | ﹤0.01% | 2229 |
|
|
2024
Q3 | $8.41M | Sell |
234,100
-77,404
| -25% | -$2.78M | ﹤0.01% | 2022 |
|
|
2024
Q2 | $11M | Buy |
311,504
+107,233
| +52% | +$3.78M | ﹤0.01% | 1907 |
|
|
2024
Q1 | $5.8M | Buy |
204,271
+33,711
| +20% | +$957K | ﹤0.01% | 2251 |
|
|
2023
Q4 | $2.27M | Buy |
170,560
+13,117
| +8% | +$174K | ﹤0.01% | 2757 |
|
|
2023
Q3 | $1.41M | Buy |
157,443
+7,196
| +5% | +$64.5K | ﹤0.01% | 2993 |
|
|
2023
Q2 | $1.69M | Buy |
150,247
+23,384
| +18% | +$263K | ﹤0.01% | 2929 |
|
|
2023
Q1 | $1.46M | Sell |
126,863
-432
| -0.3% | -$4.98K | ﹤0.01% | 2966 |
|
|
2022
Q4 | $1.48M | Buy |
127,295
+7,729
| +6% | +$89.6K | ﹤0.01% | 3007 |
|
|
2022
Q3 | $1.52M | Buy |
119,566
+10,065
| +9% | +$128K | ﹤0.01% | 2999 |
|
|
2022
Q2 | $752K | Sell |
109,501
-2,586
| -2% | -$17.8K | ﹤0.01% | 3341 |
|
|
2022
Q1 | $1.08M | Sell |
112,087
-3,860
| -3% | -$37.2K | ﹤0.01% | 3258 |
|
|
2021
Q4 | $1.38M | Sell |
115,947
-289,315
| -71% | -$3.44M | ﹤0.01% | 3200 |
|
|
2021
Q3 | $6.58M | Buy |
405,262
+15,654
| +4% | +$254K | ﹤0.01% | 2355 |
|
|
2021
Q2 | $8.2M | Buy |
389,608
+152,461
| +64% | +$3.21M | ﹤0.01% | 2245 |
|
|
2021
Q1 | $3.68M | Buy |
237,147
+86,914
| +58% | +$1.35M | ﹤0.01% | 2592 |
|
|
2020
Q4 | $3.16M | Buy |
150,233
+48,006
| +47% | +$1.01M | ﹤0.01% | 2582 |
|
|
2020
Q3 | $2.06M | Buy |
+102,227
| New | +$2.06M | ﹤0.01% | 2647 |
|